Barely Significant
← all excerpts

Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

J Immunother Cancer · 2024 · PMC11448277 · PMID 39349061

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
However, upregulation of HLA-DR was observed in patients who failed to achieve a pCR, and CD39+Treg frequencies showed a trend towards an increase throughout treatment and follow-up (non-significant).

also in 53,322 other papers

an increasing trendno p-value reported
While CTLA-4 expression in CD8+T cells was low at baseline and stayed low, its expression in Tregs was notably higher and showed an increasing trend over time.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.